US commits $4B to Covax

The U.S. on Feb. 19 pledged $4.3 billion to Covax, the international effort to ensure equitable COVID-19 vaccine distribution across the globe.

Advertisement

The administration of former President Donald Trump declined to participate in the 92-nation collaboration because it was backed by WHO, which the U.S. withdrew from July 6. President Joe Biden ordered the U.S. to rejoin WHO Jan. 20. During a Jan. 20 address to WHO, Anthony Fauci, MD, said the U.S. rejoining WHO meant it was joining Covax.

During the virtual G7 summit, President Biden committed an initial $2 billion to Covax and pledged an additional $2 billion through 2021 and 2022.

Other major countries pledged funds during the summit, with Germany committing $1.8 billion, the European Commission committing $363 million, Japan committing $79 million and Canada committing $59 million.

More articles on pharmacy:
6M COVID-19 vaccines unnecessarily stockpiled, feds say
US vaccinating average of 1.7M people per day
Pfizer COVID-19 vaccine less potent against South Africa variant, preliminary study says

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.